Voxela Officially Launches Next-Generation AI Eldercare Solution "Voxela VCare Pro"
SAN FRANCISCO — Voxela, Inc. is pleased to announce the official release of its next-generation AI eldercare solution, 'Voxela VCare Pro'. The revolutionary VCare Pro significantly reduces operational burdens for caregivers while dramatically enhancing the safety and quality of life for elders within care facilities.
Article content
Voxela VCare Pro doesn't just change how eldercare is managed—it transforms the caregiving experience, empowering facilities to deliver safer, more attentive, and more compassionate care.
Article content
Article content
https://www.voxela.ai/vcare/pro
Article content
AI-Powered Automatic Incident Reports
Upon detecting and notifying incidents such as falls, VCare Pro immediately analyzes the situation and automatically generates detailed, accurate incident reports. This significantly reduces the workload traditionally associated with manual reporting, allowing caregivers to focus more time and resources on resident care.
Incident Analytics Dashboard
This visual dashboard analyzes incident data to identify trends and patterns clearly, enabling facilities to proactively predict and implement effective preventive measures, thus reducing the recurrence of accidents.
Virtual Check-In (Remote Monitoring)
By reducing the need for periodic room visits, this function enables caregivers to perform real-time remote wellness checks. Staff can ensure residents' safety through timely and targeted interventions, effectively minimizing unnecessary room visits and significantly reducing caregiver stress.
Article content
Transforming the Eldercare Industry:
Article content
By integrating VCare Pro, care facilities can reduce indirect care duties, allowing staff to dedicate more time to essential caregiving activities. VCare Pro significantly enhances operational efficiency, resulting in more comprehensive, attentive, and safer care for elderly residents. It reduces the time spent on manual documentation, physical inspections, and on-site verifications, thereby enhancing the quality of care environments.
Article content
Already Adopted by Many Facilities:
Article content
VCare Pro has been widely implemented and highly praised by numerous eldercare facilities for its innovative and practical benefits, clearly demonstrating its effectiveness and significant positive impact on operational outcomes.
Article content
Under Voxela's vision, 'Make Aging Beautiful,' we remain committed to continuous innovation and creating solutions that address the real-world challenges of eldercare, shaping a brighter future for the caregiving industry.
Article content
Article content
Article content
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
1 Reason Why Now Is the Time to Buy Bitcoin (BTC)
Key Points Bitcoin's scarcity, with a hard cap of 21 million units, is what makes it a special asset. The digital asset's supply is enforced by a pre-determined halving schedule. Because of the burgeoning federal debt and money supply, Bitcoin's price should keep rising. 10 stocks we like better than Bitcoin › It's impossible to argue with Bitcoin 's (CRYPTO: BTC) performance. Over the past five- and 10-year periods, its price has soared 942% and 47,330%, respectively (as of Aug. 14). The gains have continued more recently, as the cryptocurrency's price is up 104% just in the last 12 months. Bitcoin now trades close to its record price. After such a monumental historical rise, investors are probably wondering if it's smart to buy this top digital asset. In my opinion, it's easy to remain bullish. Here's one must-know reason why now is the time to buy Bitcoin. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Bitcoin has a fixed supply The top reason to buy Bitcoin now is because this leading cryptocurrency has a fixed supply cap. There will only ever be 21 million units in circulation. Right now, there are 19.9 million Bitcoin units out there. The growth in supply is pre-determined by a halving event that occurs approximately every four years. Unless the majority of nodes agree to change the rules, Bitcoin's hard cap isn't going to change. Never-ending currency debasement Owning a scarce asset makes financial sense in its own right. However, when viewed next to the state of the current monetary system, the allure is strikingly clear. The U.S. carries an alarming $37 trillion in federal debt. This figure, and the money supply, have skyrocketed in the past 15 years thanks to unprecedented levels of stimulus. To get out of the Great Recession, and more recently to boost the economy following the COVID-19 pandemic, the government pumps more money into the system. Even in seemingly solid economic times, the debt and money supply expand. More fiat currency chasing a fixed amount of Bitcoin supports a much higher price for the digital asset years and decades from now. Should you invest $1,000 in Bitcoin right now? Before you buy stock in Bitcoin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bitcoin wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025
Globe and Mail
an hour ago
- Globe and Mail
Is Palantir the Next Tesla?
Key Points Tesla is a popular stock among individual investors. Palantir also doesn't have much institutional ownership. Low institutional ownership can cause a stock to challenge traditional stock market practices. 10 stocks we like better than Palantir Technologies › Palantir 's (NASDAQ: PLTR) impressive rise over the past few years has been nothing short of incredible. Still, there have also been questions surrounding Palantir's ability to deliver on the high expectations baked into the stock price. There has been no shortage of analysts calling for Palantir's fall (myself included) due to extreme valuation. This reminds me of another stock whose valuation metrics do not make a lot of sense: Tesla (NASDAQ: TSLA). However, Tesla has continued to defy traditional valuation metrics and has stayed at an elevated stock price for some time. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Could Palantir fall into this same realm? Or is it so inflated that a crash is coming? Tesla and Palantir's rise look similar Tesla stock's primary rise started in 2020, increasing from about $24 per share all the way to around today's $340 per share. It returned over 1,100% over that time frame, resulting in a rise that few stocks have ever matched. Palantir's rise has similarly been rapid and impressive. Its stock rose from around $16 to $185 at the time of this writing, resulting in about 1,000% gains. Both companies delivered impressive performance in a very short amount of time, despite not increasing their revenue by 10 times (or more) over that time frame. As a result, most investors assume that they've grown too fast and are ripe for a pullback. But this analysis excludes a significant aspect of the investment thesis. Palantir and Tesla have low institutional ownership One of the reasons why Tesla's stock did so well over that time frame is that individual investors owned it. Individual investors don't have the same mindset as institutions. Various funds and other money managers are likely more devoted to traditional valuation metrics. If their discounted cash flow (DCF) models don't work out, then they avoid the stock entirely. However, companies like Tesla and Palantir break the mold of what traditional finance teaches, which can invalidate the assumptions that go into these models. Individual investors are far more likely to take a long-term view and note that Tesla's technology and vision could allow it to deliver massive growth over the long term. This illustrates a huge difference in approaches: Institutional investors utilize trailing metrics to predict the future, while individual investors look at the world and see where it could go. This difference has allowed stocks like Tesla and Palantir to thrive, leading to massive market outperformance as individual investors are less concerned with traditional valuation measures. Whether you think that's a correct approach to these two stocks or not is irrelevant; it's what's going on. Luckily, we have access to a metric that measures the percentage of shares outstanding that institutions own. For Tesla, about 49% of shares outstanding are institutionally owned. Compared to other tech giants, this is rather low. For comparison, Alphabet and Meta Platforms each have about 78% of shares outstanding owned by institutional investors. That's quite the difference and shows how much individuals, rather than large institutions, own Tesla. Palantir is in the same territory as Tesla, with about 53% of shares owned by institutions. Compared to the two closest companies in market cap to Palantir, Costco and ExxonMobil, these two have 69% and 67% of shares owned by institutional investors, respectively. Because Palantir has a similarly small amount of shares owned by institutional investors as Tesla, the stock will likely continue to perform in a manner that some may consider irrational. The decision to invest in Palantir is up to you, but investors need to be aware that after Tesla's massive run, the stock became incredibly volatile. Palantir could be approaching that point, but we'll find out in the coming years. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Keithen Drury has positions in Alphabet, Meta Platforms, and Tesla. The Motley Fool has positions in and recommends Alphabet, Costco Wholesale, Meta Platforms, Palantir Technologies, and Tesla. The Motley Fool has a disclosure policy.
CBC
2 hours ago
- CBC
What health experts are saying about Alberta's COVID-19 vaccination program
Social Sharing Health experts, advocates and unions are sounding the alarm over Alberta's plan for paid COVID-19 shots, calling it concerning and confusing. On Monday, two months after the province announced it was adding a fee, it opened online pre-ordering for the vaccine. Albertans still need to book appointments for the shots, starting in October. Dr. James Talbot, the province's former chief medical officer of health, said the government appears to be doing everything it can to make this year's immunization campaign a "failure" by making it less available, less accessible and less affordable. "They are basically sabotaging their own COVID campaign," he said. He's among a chorus of critics warning it could lead to more hospitalizations and stress on the health-care system. Talbot and other public health experts and physicians penned an opinion piece in the Edmonton Journal last week, arguing the plan creates unfair barriers and puts Albertans at risk. "You've created this unfairness where if you're rich, you can get protected, but if you're poor, you may not be able to," Talbot said. Leigh Allard, president and CEO of Alberta Lung, part of the National Lung Health Alliance, said the government's policy makes it an extreme outlier and its precedent could ripple across the country. Those who suffer from lung conditions like asthma, cystic fibrosis or pulmonary fibrosis are vulnerable, she added. This year, Albertans also won't be able to walk into a pharmacy to get a COVID-19 shot, where the vast majority of doses were given last year. They must go to a public health clinic. Allard said people are confused over the plan. She's also concerned many won't be able to access a clinic for a shot, especially if hours aren't extended, or some simply won't be able to afford it. She said she expects an uptake in Alberta Lung's financial assistance programs. "As a charity, we should not be supplementing what the government should be doing." The government said it will still pay for some to get shots, including those who have compromised immune systems or are on social programs. Seniors in congregate settings will also be covered. However, the specifics of the qualifying health conditions have not been released. It's estimated a shot could cost $110, but the government has yet to pin down the price. Kyle Warner, spokesperson for Primary and Preventative Health Minister Adriana LaGrange, said details are forthcoming. "The fall immunization plan is being finalized, and details — including the updated vaccination schedule, eligible conditions, exact locations and administrative fee for COVID-19 vaccines — will be available soon," he said in a statement. Warner also said Albertans who don't pre-order by the Sept. 30 deadline can still book a vaccine appointment once doses become available. He said online pre-ordering helps determine future vaccine needs, minimize waste, manage delivery and prevent double bookings, since the influenza vaccine can be given at the same time. Those who pre-order are promised a reminder in October to book an appointment. The province said it has ordered 485,000 doses of COVID-19 vaccine for the fall and some of the estimated $49-million cost would be covered through those who have to pay. The government didn't respond to questions about whether it has a contingency plan to order more doses if needed, whether out-of-province costs might be reimbursed, and what informed its decision to order 250,000 fewer doses than last year. It also didn't clarify whether flu shots, which remain free, would be available in pharmacies. The province's interim chief medical officer of health, Dr. Sunil Sookram, wasn't made available for an interview. Talbot called withholding the specifics disrespectful. "It's bad enough that there's a list that says you're going to ration it, but then to have confusion about who's on the list — that just seems cruel," he said. The province has said an estimated one million COVID-19 vaccine doses, or just over half of Alberta's supply, weren't used during the 2023-24 respiratory virus season. Premier Danielle Smith has said that meant $135 million was "flushed down the drain." Facing heated questions about the policy at a public town hall in Edmonton on Thursday, Smith said her United Conservative Party government is trying not to waste public money. "There are lots of different types of vaccines that are paid for out of pocket right now ... because the federal government defunded it," she said, pointing to shots for yellow fever, which also need to be purchased. The latest provincial data says 394 Albertans with confirmed COVID-19 have died since last August. Talbot and labour leaders have also said the plan puts health workers in harm's way, and potentially forces those in an already strained system to take sick time off work to avoid infecting others. "You're going to be the only province in the country that says we care so little about these people that we're going to force them to pay for their own vaccine," said Talbot. "It seems inconceivable to me that a rational mind would think that was a good way to recruit and retain health-care professionals." Unions warned this week of potential fallout. In a Tuesday letter to the premier, Alberta Federation of Labour president Gil McGowan wrote it would be a violation of workplace health and safety laws not to include all health workers, education workers, transit operators and those in the service sector on its priority list. McGowan said he's also hearing frustration and confusion from front-line members. "It's not just incompetence. This is clearly not a vaccine rollout strategy. It's a vaccine suppression strategy," he said. The United Nurses of Alberta has said the plan limits the freedom of Albertans to choose vaccination by intentionally limiting supply and penalizing those who can't afford it.
